EXCLUSIVE: Blockchain, Biotech, Bad Guys — Canurta Therapeutics CEO Is On A Mission To Heal, And He’s Just Getting Started
Posted On May 29, 2025
Toronto might be known for the CN Tower and the Raptors, but during Consensus 2025, it was Canurta Therapeutics’ CEO Akeem Gardner who stole the show – not just for repping his hometown, but for blending biotech, blockchain, and bold storytelling.
In an exclusive sit-down with Benzinga’s Dan Leach, Gardner laid out Canurta’s mission: mining nature’s rarest molecules to treat complex diseases, starting with ALS (amyotrophic lateral sclerosis). But his vision goes far beyond the lab. He’s fusing the power of Web3 with the high-stakes world of drug development – and gamifying it in the process.
Read Also: Rocket Pharma’s Gene Therapy Future …
About The Author
